Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine

ORCID: 0000-0001-8901-7850

Publication year:
All
1 - 10 out of 26Page size: 10
  1. 2015
  2. Published

    Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America

    Efsen, A. M. W., Schultze, A., Post, F. A., Panteleev, A., Furrer, H., Miller, R. F., Losso, M. H., Toibaro, J., Skrahin, A., Miro, J. M., Caylà, J. A., Girardi, E., Bruyand, M., Obel, Niels, Podlekareva, Daria, Lundgren, Jens, Mocroft, A., Kirk, Ole & TB:HIV study group in EuroCoord, T. S. G. I. E., 2015, In: P L o S One. 10, 12, p. 1-17 17 p., e0145380.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Projected Lifetime Healthcare Costs Associated with HIV Infection

    Nakagawa, F., Miners, A., Smith, C. J., Simmons, R., Lodwick, R. K., Cambiano, V., Lundgren, Jens, Delpech, V. & Phillips, A. N., 2015, In: PloS one. p. 1-12 12 p., e0125018.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Mild induced hypothermia: Effects on sepsis-related coagulopathy -results from a randomized controlled trial

    Johansen, M. E., Jensen , Jens-Ulrik Stæhr , Bestle, Morten Heiberg, Ostrowski, Sisse Rye, Thormar, K., Christensen, H., Pedersen, H. P., Poulsen, L., Mohr, T., Kjær, J., Cozzi-Lepri, A., Møller, Kirsten, Tønnesen, E., Lundgren, Jens & Johansson, P. I., Jan 2015, In: Thrombosis Research. 135, 1, p. 175-182 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Profound Endothelial Damage Predicts Impending Organ Failure and Death in Sepsis

    Johansen, M. E., Johansson, P. I., Ostrowski, Sisse Rye, Bestle, Morten Heiberg, Hein, L., Jensen, A. L. G., Søe-Jensen, P., Andersen, Mads Hald, Steensen, M., Mohr, T., Thormar, K., Lundgren, B., Cozzi-Lepri, A., Lundgren, Jens & Jensen, J., Feb 2015, In: Seminars in Thrombosis and Hemostasis. 41, 1, p. 16-25 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

    Mocroft, A., Lundgren, Jens, Ross, M., Law, M., Reiss, P., Kirk, Ole, Smith, C., Wentworth, D., Neuhaus, J., Fux, C. A., Moranne, O., Morlat, P., Johnson, M. A., Ryom, L. & D:A:D Study Group, D. S. G., Mar 2015, In: PLoS ONE. 12, 3, p. 1-31 e1001809.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Invasive Candida Infections and the Harm From Antibacterial Drugs in Critically Ill Patients: Data From a Randomized, Controlled Trial to Determine the Role of Ciprofloxacin, Piperacillin-Tazobactam, Meropenem, and Cefuroxime

    Jensen, J. U. S., Hein, L., Lundgren, B., Bestle, M. H., Mohr, T., Andersen, M. H., Løken, J., Tousi, H., Søe-Jensen, P., Lauritsen, A. Ø., Strange, D., Petersen, J. A., Thormar, K., Larsen, K. M., Drenck, N. E., Helweg-Larsen, J., Johansen, M. E., Reinholdt, K., Møller, J. K., Olesen, B. & 6 others, Arendrup, M. C., Østergaard, C., Cozzi-Lepri, A., Grarup, J., Lundgren, Jens & Procalcitonin and Survival Study Group, P. A. S. S. G., Mar 2015, In: Critical Care Medicine. 43, 3, p. 594-602 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

    Sharma, S., Babiker, A. G., Emery, S., Gordin, F. M., Lundgren, Jens, Neaton, J. N., Bakowska, E., Schechter, M., Wiselka, M. J., Wolff, M. J. & International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group, I. N. F. S. I. I. G. H. T. (. S. S. G., Apr 2015, In: HIV Medicine. 16 , Suppl 1, p. 30-6 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

    Baxter, J. D., Dunn, D., White, E., Sharma, S., Geretti, A. M., Kozal, M. J., Johnson, M. A., Jacoby, S., Llibre, J. M., Lundgren, Jens & International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group, I. N. F. S. I. I. G. H. T. (. S. S. G., Apr 2015, In: HIV Medicine. 16 , suppl 1, p. 77-87 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Why START? Reflections that led to the conduct of this large long-term strategic HIV trial

    Lundgren, Jens, Babiker, A., Gordin, F., Emery, S., Fätkenheuer, G., Molina, J., Wood, R., Neaton, J. D. & INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, I. S. T. O. A. T. (. S. G., Apr 2015, In: HIV Medicine. 16 , Suppl 1, p. 1-9 9 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  11. Published

    Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study

    Bruyand, M., Ryom, L., Shepherd, L., Fatkenheuer, G., Grulich, A., Reiss, P., de Wit, S., D Arminio Monforte, A., Furrer, H., Pradier, C., Lundgren, Jens, Sabin, C. & D:A:D Study Group, D. S. G., 15 Apr 2015, In: Journal of acquired immune deficiency syndromes (1999). 68, 5, p. 568-77 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 Next

ID: 13961